Objective Positive fluid balance is common among critically ill patients and leads to worse
outcomes, particularly in sepsis, acute respiratory distress syndrome, and acute kidney …

Background Human albumin infusion is effective for controlling systemic inflammation,
thereby probably managing some liver cirrhosis-related complications, such as spontaneous …

Abstract Background & Aims Numerous studies have evaluated the role of human albumin
(HA) in managing various liver cirrhosis-related complications. However, their conclusions …

Background. Hyponatremia is a common complication of liver cirrhosis and aggravates
patients' outcomes. It may be corrected by human albumin (HA) infusion. Herein, we have …

Introduction Use of albumin is suggested for some patients with shock, but preferences for its
use may vary among intensive care unit (ICU) physicians. Methods We conducted an …

The use of albumin in patients with cirrhosis has been extensively discussed over recent
years. Current treatment approaches depend on targeting related complications, aiming to …

Since 1940 albumin has been used worldwide and is widely available commercially since
this time. However, a meta-analysis in 1998 challenged the use of albumin and identified a …

Abstract The Saline versus Albumin Fluid Evaluation (SAFE) study has demonstrated that
the use of albumin as an infusion solution in volume therapy can be regarded as safe. An …

Background Plasma volume expanders are used in connection to paracentesis in people
with cirrhosis to prevent reduction of effective plasma volume, which may trigger deleterious …

Background: Human albumin (HA) infusion is potentially effective for the management of
hyponatremia in liver cirrhosis, but the current evidence is very limited. Methods: In this …